ArcticZymes Technologies Announces Nomination of Dr. Frank Mathias as Chairman of the Board

25 Jun 2024 08:26 CEST

Tromsø, Norway - June 25, 2024 - ArcticZymes Technologies (OSE:AZT) is pleased
to announce the nomination of Dr. Frank Mathias as the new Chairman of the
Board.

Dr. Mathias is the CEO at Oxford Biomedica, a leading pure-play CDMO within the
cell and gene therapy industry. Dr. Mathias was previously the CEO of Rentschler
Biopharma SE, which he successfully developed into a leading global, full
-service CDMO. Prior to Rentschler, Dr. Mathias served as CEO of Medigene AG, a
publicly listed immuno-oncology company. During his 30-year career, Dr. Mathias
has held senior roles at leading global pharmaceutical companies, including
Amgen Deutschland GmbH, Servier Deutschland GmbH, and Hoechst AG. In 2019, he
was awarded the "EY Entrepreneur of the Year" title in Germany. Dr. Mathias is a
pharmacist by training and completed his Doctorate in Pharmacy at Paris VI
University.

"We are very pleased to nominate Frank Mathias as our new Chairman of the
Board," said Jon R. Sandberg, Chairman of the Nomination Committee. "Frank
Mathias' extensive experience and visionary leadership make him the ideal
candidate to guide our company into its next phase of development,
commercialization and growth."

"I am honoured to join ArcticZymes at such a pivotal time," said Dr. Frank
Mathias. "The innovative enzyme solutions developed by ArcticZymes have made
significant contributions to advancements in biomanufacturing, enhancing
efficiency and quality across the industry. I look forward to contributing to
the company's continued success and collaborative growth."

For more information, please contact:

ArcticZymes Technologies ASA

CEO, Michael B. Akoh Tel: +46 (0) 70 262 37 15

ir@arcticzymes.com

About ArcticZymes Technologies ASA:

ArcticZymes Technologies ASA (OSE: AZT) is a global leader in supplying best-in
-class enzyme technologies to commercial partners who develop therapeutics, in
vitro diagnostics, and molecular research kit products. Our mission is to make
our customers lives easier by unlocking new solutions to enhance quality of life
and create a more sustainable healthy world.

More information:
Access the news on Oslo Bors NewsWeb site

622297_Nom_chariman_to_the_board.pdf